Apellis Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APLS and other ETFs, options, and stocks.About APLS
Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE.
APLS Key Statistics
Stock Snapshot
Apellis Pharmaceuticals(APLS) stock is priced at $22.19, giving the company a market capitalization of 2.81B. It carries a P/E multiple of 71.57.
During the trading session on 2025-12-04, Apellis Pharmaceuticals(APLS) shares reached a daily high of $22.45 and a low of $21.09. At a current price of $22.19, the stock is +5.2% higher than the low and still -1.2% under the high.
Trading activity shows a volume of 2.54M, compared to an average daily volume of 2.04M.
The stock's 52-week range extends from a low of $16.10 to a high of $35.72.
The stock's 52-week range extends from a low of $16.10 to a high of $35.72.
APLS News
In trading on Thursday, shares of Apellis Pharmaceuticals Inc (Symbol: APLS) crossed above their 200 day moving average of $42.80, changing hands as high as $42...
Apellis Pharmaceuticals (APLS) has released new results from its Phase 3 GALE extension study. The findings highlight that SYFOVRE slowed disease progression fo...
